AvantGuard, Inc.

AvantGuard, Inc. is a chemical manufacturing company and Cornell University spin-out that specializes in advanced antimicrobial technologies [2, 4]. Originally founded in 2018 as Halomine, the company develops proprietary molecules and polymers, such as its Avantamine technology and N-halamine-based solutions, designed to provide long-term, broad-spectrum protection against bacteria, viruses, and fungi, including Candida auris [1, 2, 4, 6]. These innovations mimic natural immune responses and utilize specialized chemistry to extend the efficacy of standard disinfectants or provide durable antimicrobial coatings and additives for various surfaces, materials, and medical applications [1, 5, 6, 8].

By addressing the limitations of temporary, short-term disinfectants, AvantGuard’s solutions are intended to safeguard healthcare environments, food processing facilities, and personal skin health while helping to reduce the reliance on systemic antibiotics [2, 4, 7]. The company supports its research through partnerships with academic institutions and funding from organizations such as the National Institutes of Health [2, 4]. It is actively pursuing FDA applications for clinical treatments, including wound dressings and dermatological applications, to combat challenging infections such as diabetic foot ulcers and fungal skin conditions, representing significant potential impact in global health and medical markets [1, 2, 5, 6].